The Promise of Low Dose Naltrexone Therapy: Potential Benefits in Cancer, Autoimmune, Neurological and Infectious Disorders

Voorkant
McFarland, 22 jan. 2009 - 223 pagina's
0 Recensies
Reviews worden niet geverifieerd, maar Google checkt wel op nepcontent en verwijdert zulke content als die wordt gevonden.
Naltrexone is an opiate antagonist drug developed in the 1970s and approved by the FDA in 1984 for opiate and drug abuse treatment. When used at much lower doses in an off-label protocol referred to as low dose naltrexone (LDN), the drug has been shown to halt disease progression in Crohn's disease and certain cancers, to reduce symptoms in multiple sclerosis and autism, and to improve numerous autoimmune and neurodegenerative conditions, including Parkinson's disease and amyotrophic lateral sclerosis (ALS). Grounded in clinical and scientific research, this book describes the history of naltrexone, its potential therapeutic uses, its effects on the immune system, its pharmacological properties, and how the drug is administered. It also lists fillers and compounding pharmacies, doctors who prescribe LDN, and patient resources, and includes interviews with LDN patients and researchers.
 

Wat mensen zeggen - Een review schrijven

We hebben geen reviews gevonden op de gebruikelijke plaatsen.

Inhoudsopgave

1 The War on Drugs A History of Naltrexone
11
2 LDN in Autoimmune Diseases
29
3 LDN in Multiple Sclerosis
45
4 LDN in Neurodegenerative Disorders
61
5 LDN in Cancer
78
6 LDN in Autism Spectrum Disorders
95
7 LDN in Wound Healing and Infections
102
8 The Immune System and LDN in HIVAIDS
108
9 The LDN Experience
126
10 The Potential Benefits and Future of LDN
148
Chapter Notes
159
Glossary
167
Appendix
179
Resources
189
Index
209
Copyright

Overige edities - Alles bekijken

Veelvoorkomende woorden en zinsdelen

Over de auteur (2009)

Elaine A. Moore has worked in hospital laboratories for more than 30 years, primarily in immunohematology and toxicology. She is a freelance medical writer and laboratory consultant. For more information, visit her website at www.elaine-moore.com. She lives in Sedalia, Colorado. Samantha Wilkinson is a patient advocate for multiple sclerosis and LDN. Through her website www.ldners.org she educates patients about current LDN research. She lives in Edmonds, Washington.

Bibliografische gegevens